Literature DB >> 8585850

The therapeutic efficacy and prophylactic activity of doramectin against Dictyocaulus viviparus in cattle.

N J Barton1, P J Mitchell, F G Hooke, J Reynolds.   

Abstract

Three groups of 8, 4-month-old male Jersey or Jersey-cross calves were infected with 2400 Dictyocaulus viviparus L3 larvae and either left untreated or injected subcutaneously with 200 micrograms/kg doramectin 5 or 25 days after infection (DAI). Lungworms were found in all untreated cattle (geometric mean = 49) at necropsy 39 or 40 DAI. None was found in any of the treated cattle. In a second experiment, groups of 6, 8-month-old calves were untreated or injected with 200 micrograms/kg doramectin 28, 21 or 14 days before each calf was challenged with 2700 D viviparus larvae. Lungworms were recovered at necropsy 32 to 34 DAI. The geometric mean worm burden in the untreated cattle was 550. This was reduced by 100%, 99.5% and 94.1% in calves treated with doramectin 14, 21 or 28 days, respectively, before infection. It was concluded that doramectin is a highly effective anthelmintic against D viviparus adult or L4 infections of cattle, and that reinfection of treated cattle will be significantly reduced for at least 28 days after treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8585850     DOI: 10.1111/j.1751-0813.1995.tb07540.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  2 in total

1.  Niosomal versus nano-crystalline ivermectin against different stages of Trichinella spiralis infection in mice.

Authors:  Dalia A Elmehy; Marwa A Hasby Saad; Gamal M El Maghraby; Mona F Arafa; Nema A Soliman; Heba H Elkaliny; Dina I Elgendy
Journal:  Parasitol Res       Date:  2021-05-04       Impact factor: 2.289

2.  Therapeutic potential of myrrh and ivermectin against experimental Trichinella spiralis infection in mice.

Authors:  Maha M A Basyoni; Abdel-Aleem A El-Sabaa
Journal:  Korean J Parasitol       Date:  2013-06-30       Impact factor: 1.341

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.